References
1 Styblo K. Epidemiology of Tuberculosis. KNCV Selected Papers 1991; 24: 1-136
2 Rieder HL. Epidemiology of tuberculosis in Europe. Eur Respir J 1995; 8 (suppl 20): 620s-632s.
3 Wilson R, ed. Tuberculosis. European Respiratory Monographs 1997; 2 (4): 353 pages
4 Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull Wld Health Org 1994; 72: 213-220
5 Raviglione MC, Sudre P, Rieder HL, Spinaci S, Kochi A. Secular trends of tuberculosis in Western Europe. Bull Wld Hlth Org 1993; 71: 297-306
6 Comstock GW. Tuberculosis--a bridge to chronic disease epidemiology. Am J Epidemiol 1986, 124: 1-16.
7 Andvord KF. Der Verlauf der Tuberculose durch Generationen, Beitr Klin Tuberk 1930; 75: 552-563
8 Heimbeck J. Tuberculosis in hospital nurses. Tubercle 1936; 18: 97-99
9 Frost WH. The age selection of mortality from tuberculosis in successive decades. Am J Hyg 1939; 30: 91-96
10 Terris M. Relation of economic status to tuberculosis mortality by age and sex. Am J Pub Health 1948; 38: 1061-1070
11 Horwitz O, Palmer CE. Epidemiological basis of tuberculosis eradication. 2. Dynamics of tuberculosis morbidity and mortality. Bull Wld Health Org 1964; 30: 609-621
12 Grzybowski S, Allen EA. The challenge of tuberculosis in decline. Am Rev Respir Dis 1964; 90: 707-720
13 Rouillon A, Perdrizet S, Parrot R. Transmission of tubercle bacilli: the effects of chemotherapy. Tubercle 1976; 57: 275-299
14 Comstock GW. Epidemiology of tuberculosis. Am Rev Respir Dis 1982; 125: 8-15
15 Styblo K. The epidemiological situation of tuberculosis and the impact of control measures. Bull Int Union Tuberc 1983; 58: 179-186
16 Snider DE. Research towards global control and prevention of tuberculosis with an emphasis on vaccine development. Rev Infect Dis 1989; 11 (suppl 2): S336-S338
17 Rieder HL, Cauthen GM, Comstock GW, Snider DE. Epidemiology of tuberculosis in the United States. Epidemiol Rev 1989; 11: 79-98
18 Fine PEM. Herd immunity: history, theory and practice. Epidemiological Reviews 1993; 15: 265-302
19 Waaler HT, Piot MA. The use of an epidemiological model for estimating the effectiveness of tuberculosis control measures. Sensitivity of the effectiveness of tuberculosis control measures to the coverage of the population. Bull Wld Health Org 1969; 41: 75-93
20 Last J. A Dictionary of Epidemiology. Oxford: Oxford University Press. 1995: 60.
21 Rieder HL. Opportunity for exposure and risk of infection: the fuel for the tuberculosis pandemic. Infection 1995; 23: 5-8
22 Shaw JB, Wynn-Williams N. Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc 1954; 69: 724-732
23 Grzybowski S, Barnett GD, Styblo K. Contacts of cases of active pulmonary tuberculosis. Bull Int Un Tuberc 1975; 50: 90-106
24 Nissen Meyer S, Dahlstrom G. Tuberculosis in BCG vaccinated and non vaccinated young adults. Acta Tuberc Scand 1953; 32(suppl).
25 Daniels M, Ridehalgh F, Springett VH, Hall IM. Tuberculosis in young adults. London: Lewis. 1948
26 Wallgren A. The time table of tuberculosis. Tubercle 1948; 29: 245-251
27 Ferebee SH, Mount FW. Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts. Am Rev Respir Dis 1962; 85: 490-510
28 D'Arcy Hart P, Sutherland I. Final report of the Medical Research Council by its Tuberculosis Vaccines Clinical Trials Committee. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J 1977; ii: 293-295
29 Jones BE, Ryu R, Yang Z, Cove MD. Pogoda JM, Otaya M, Barnes PF. Chest radiographic studies in patients with tuberculosis with recent or remote infection. Am J Resp Crit Care Med 1997; 156: 1270-1273
30 Selwyn PA Hartel D, Lewis VA, Schoenbaum EE, Vermund SH. Klein RS, Walker AT, Friedland GH. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320: 345-350
31 Springett VH. Ten-year results during the introduction of chemotherapy for tuberculosis. Tubercle 1971; 52: 73-87
